Clinical Trials Sponsored by LycoRed Ltd.

Total 16973 results

LycoRed Ltd.

Withdrawn

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Skin Parameters in Healthy Female Subjects

Skin

United States
LycoRed Ltd.

Completed

Evaluation of the Nutritional Supplement Lycoderm on Its Impact on Skin Parameters (Lycoderm)

Skin Care

United States
LycoRed Ltd.

Completed

A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants.

Skin

United States
LycoRed Ltd.

Completed

A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato

Skin

United States
LycoRed Ltd.

Completed

Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms | BPH

United States
LycoRed Ltd.

Completed

Effect of Tomato Extracted Lycopene on Postprandial Oxidation and inﬂammation in Healthy Weight Men and Women

Postprandial Oxidation and inﬂammation

Israel
LycoRed Ltd.
ObvioHealth

Completed

Lumenato Nutritional Supplement on Skin Appearance

Skin

United States
Appalachian State University
LycoRed Ltd.

Completed

Astaxanthin, Exercise Inflammation, Skin Health

Inflammatory Response | Metabolic Disturbance | Immune Suppression

United States
Appalachian State University
LycoRed Ltd.

Completed

LycoRed 40051 Product as a Countermeasure to Exercise Stress

Inflammation

United States
LycoRed Ltd.
Maccabi Healthcare Services, Israel

Completed

Effect of Cardio Mato (Grade A Lyc-O-Mato, a Tomato Extracted Lycopene) on Blood Pressure

Prehypertension

Israel
LycoRed Ltd.
Indiana University School of Medicine

Completed

The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow

Ocular Blood Flow

United States
LycoRed Ltd.
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

A Study to Evaluate the Effect of Astaxanthin in Healthy Participants

Healthy

United States
Nycomed

Completed

Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)

Osteoporosis

Denmark
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD) (PANTHER)

Gastroesophageal Reflux Disease

Germany
Nycomed

Completed

Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders (PANDA)

Gastroesophageal Reflux Disease | Sleep Disorders | Non-Erosive Reflux Disease

Germany
Nycomed

Completed

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease (PARADE)

Gastroesophageal Reflux Disease

Germany
Nycomed

Withdrawn

RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)

Coronary Disease
Nycomed

Completed

ImproveR International (BI-001-IM)

Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)

Denmark
Nycomed

Terminated

The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)

Back Pain

Denmark
Nycomed

Completed

Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)

Colorectal Anastomosis

Germany, Netherlands, United Kingdom
Nycomed

Completed

Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil®

Hemorrhage

Germany
Nycomed

Completed

PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

Osteoporosis | Postmenopause

Germany
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)

Gastroesophageal Reflux

Germany
Nycomed

Completed

TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)

Intraoperative Complications | Pulmonary Diseases

Denmark
Nycomed

Completed

Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Cancer

Denmark
Nycomed

Completed

Non-interventional Trial About Treatment of Haemorrhages in Cholecystectomy With TachoSil (TC-027-DE)

Hemorrhage

Denmark
Nycomed

Completed

TachoSil Paediatric Liver Trial (TC-019-IN)

Liver Diseases

Denmark
Nycomed

Completed

Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)

Pain | Cancer

Denmark
Nycomed

Completed

OSHES - Observational Study on Hemostasis in Surgery (TC-022-IT)

Blood Loss, Surgical | Hemostasis

Denmark
Nycomed

Completed

Matrifen® for Therapy of Severe Chronic Pain® (Matrix LQ)

Severe Chronic Pain

Germany
Nycomed

Completed

TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)

Haemorrhage | Cardiovascular Surgery | Haemostasis

Denmark
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS) (PULS)

Erosive Gastroesophageal Reflux Disease | Non-Erosive Reflux Disease

Germany
Nycomed

Completed

Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)

Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain.
Nycomed

Completed

STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)

Postmenopausal Women With Primary Osteoporosis

Denmark
Nycomed

Completed

Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic Pain (MATRIX II)

Severe, Chronic Pain

Germany
Nycomed

Completed

Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)

Symptomatic Diabetic Peripheral Polyneuropathy

Denmark
Nycomed

Completed

Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers

Healthy

Germany
Nycomed

Completed

Observational Cohort Study of TachoSil (TC-018-IN)

Blood Loss, Surgical

Denmark
Nycomed

Completed

Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

Common Cold
Nycomed

Completed

Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)

Pain

Denmark
Nycomed

Completed

Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers

Type 2 Diabetes Mellitus

Germany
Nycomed

Completed

Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)

Control of Local Bleeding in Patients Undergoing Prostatectomy.

Denmark
Durect
Nycomed

Completed

A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery

Postoperative Pain

New Zealand, Australia
Durect
Nycomed

Completed

An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder Surgery

Postoperative Pain

Austria, Germany, Latvia, Poland, Sweden
Durect
Nycomed

Completed

An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy

Postoperative Pain

France, Germany, Hungary, Latvia, Sweden, United Kingdom
Durect
Nycomed

Completed

A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair

Postoperative Pain | Hernia | Surgery

New Zealand, Australia
Nycomed
NPS Pharma

Completed

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Renal Impairment

Germany
AstraZeneca
Nycomed GmbH

Completed

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma (RAINBOW)

Asthma

Hungary, South Africa, Russian Federation, Spain, Poland, Germany, Bulgaria, Romania, Ukraine
Shire
Nycomed

Completed

Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects (STEPS)

Short Bowel Syndrome

United States, Spain, France, Canada, Netherlands, Denmark, Germany, Italy, Poland, United Kingdom
Fougera Pharmaceuticals Inc.

Withdrawn

To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis

Plaque Psoriasis

3

Subscribe